Amarin (AMRN) -6.8% after saying that doesn't expect a decision from the FDA this month on...

|About: Amarin Corporation PLC (AMRN)|By:, SA News Editor

Amarin (AMRN) -6.8% after saying that doesn't expect a decision from the FDA this month on whether to grant the company's request for five-year marketing exclusivity for its Vascepa heart pill, which the agency approved in July. Amarin doesn't haven't a clue whether the FDA will grant its request or when it will make a decision.